5l3l: Difference between revisions

Line 1:

~~'''Unreleased structure'''~~

~~The entry~~ 5l3l is ~~ON HOLD~~

==D11 bound IGF-II==

~~Authors~~: ~~Hexnerova~~, R.

== Structural highlights ==

<table><tr><td colspan='2'>[[5l3l]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L3L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5L3L FirstGlance]. <br>

~~Description~~: ~~D11 bound IGF~~-II

</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l3l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l3l OCA], [http://pdbe.org/5l3l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l3l RCSB], [http://www.ebi.ac.uk/pdbsum/5l3l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l3l ProSAT]</span></td></tr>

[[~~Category~~: ~~Unreleased Structures~~]]

</table>

== Disease ==

[[http://www.uniprot.org/uniprot/IGF2_HUMAN IGF2_HUMAN]] Epigenetic changes of DNA hypomethylation in IGF2 are a cause of Silver-Russell syndrome (SRS) [MIM:[http://omim.org/entry/180860 180860]]. A clinically heterogeneous condition characterized by severe intrauterine growth retardation, poor postnatal growth, craniofacial features such as a triangular shaped face and a broad forehead, body asymmetry, and a variety of minor malformations. The phenotypic expression changes during childhood and adolescence, with the facial features and asymmetry usually becoming more subtle with age.<ref>PMID:19066168</ref>

== Function ==

[[http://www.uniprot.org/uniprot/IGF2_HUMAN IGF2_HUMAN]] The insulin-like growth factors possess growth-promoting activity. In vitro, they are potent mitogens for cultured cells. IGF-II is influenced by placental lactogen and may play a role in fetal development.<ref>PMID:16912056</ref> Preptin undergoes glucose-mediated co-secretion with insulin, and acts as physiological amplifier of glucose-mediated insulin secretion. Exhibits osteogenic properties by increasing osteoblast mitogenic activity through phosphoactivation of MAPK1 and MAPK3.<ref>PMID:16912056</ref>

== References ==

__TOC__

</StructureSection>

[[Category: Hexnerova, R]]

[[Category: Cell cycle]]

[[Category: Igf-ii]]

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
-The entry 5l3l is ON HOLD
+==D11 bound IGF-II==
+<StructureSection load='5l3l' size='340' side='right' caption='[[5l3l]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''>
-Authors: Hexnerova, R.
+== Structural highlights ==
+<table><tr><td colspan='2'>[[5l3l]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L3L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5L3L FirstGlance]. <br>
-Description: D11 bound IGF-II
+</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l3l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l3l OCA], [http://pdbe.org/5l3l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l3l RCSB], [http://www.ebi.ac.uk/pdbsum/5l3l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l3l ProSAT]</span></td></tr>
-[[Category: Unreleased Structures]]
+</table>
+== Disease ==
+[[http://www.uniprot.org/uniprot/IGF2_HUMAN IGF2_HUMAN]] Epigenetic changes of DNA hypomethylation in IGF2 are a cause of Silver-Russell syndrome (SRS) [MIM:[http://omim.org/entry/180860 180860]]. A clinically heterogeneous condition characterized by severe intrauterine growth retardation, poor postnatal growth, craniofacial features such as a triangular shaped face and a broad forehead, body asymmetry, and a variety of minor malformations. The phenotypic expression changes during childhood and adolescence, with the facial features and asymmetry usually becoming more subtle with age.<ref>PMID:19066168</ref>
+== Function ==
+[[http://www.uniprot.org/uniprot/IGF2_HUMAN IGF2_HUMAN]] The insulin-like growth factors possess growth-promoting activity. In vitro, they are potent mitogens for cultured cells. IGF-II is influenced by placental lactogen and may play a role in fetal development.<ref>PMID:16912056</ref>   Preptin undergoes glucose-mediated co-secretion with insulin, and acts as physiological amplifier of glucose-mediated insulin secretion. Exhibits osteogenic properties by increasing osteoblast mitogenic activity through phosphoactivation of MAPK1 and MAPK3.<ref>PMID:16912056</ref>
+== References ==
+<references/>
+__TOC__
+</StructureSection>
 [[Category: Hexnerova, R]]
+[[Category: Cell cycle]]
+[[Category: Igf-ii]]